|
A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Mark I. van Berge Henegouwen |
Consulting or Advisory Role - Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Medtronic (Inst); Medtronic (Inst); Medtronic (Inst); Medtronic (Inst); Mylan (Inst); Mylan (Inst); Mylan (Inst); Mylan (Inst) |
Research Funding - Olympus (Inst); Olympus (Inst); Olympus (Inst); Olympus (Inst); Stryker (Inst); Stryker (Inst); Stryker (Inst); Stryker (Inst) |
Travel, Accommodations, Expenses - Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson |
|
|
No Relationships to Disclose |
|
Hanneke W.M. Van Laarhoven |
Honoraria - Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone |
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Nordic Group; Nordic Group; Nordic Group; Nordic Group; Servier; Servier; Servier; Servier |
Research Funding - Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Nordic Group (Inst); Nordic Group (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Philips Healthcare (Inst); Philips Healthcare (Inst); Philips Healthcare (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Servier (Inst); Servier (Inst); Servier (Inst); Servier (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca |
|
|
No Relationships to Disclose |